Evaluation of the effect of SMA-pirarubicin micelles on colorectal cancer liver metastases and of hyperbaric oxygen in CBA mice

Journal of Drug Targeting

Volumn 15, Issue 7-8, 2007, Pages 487-495

  Daruwalla, Jurstine ^a   Greish, Khaled ^b   Nikfarjam, Mehrdad ^a   Millar, Ian ^c   Malcontenti Wilson, Cathy ^a   Iyer, Arun K ^b   Christophi, Chris ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b SOJO UNIVERSITY   (Japan)

^c ALFRED HOSPITAL   (Australia)

Author keywords

Colorectal cancer; EPR effect; Liver metastases; Micelle; Novel therapuetics; Pirarubicin

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTHRACYCLINE DERIVATIVE; BILIRUBIN; CREATININE; OXYGEN; PIRARUBICIN; REACTIVE OXYGEN METABOLITE; STYRENE MALEIC ANHYDRIDE COPOLYMER;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW TOXICITY; CARDIOTOXICITY; COLORECTAL CANCER; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE MODEL; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG PENETRATION; DRUG POTENCY; DRUG RETENTION; DRUG SELECTIVITY; DRUG TUMOR LEVEL; HEMATOCRIT; HYPERBARIC OXYGEN; LIVER METASTASIS; LIVER TOXICITY; MACROMOLECULE; MALE; MAXIMUM TOLERATED DOSE; MICELLE; MONOTHERAPY; MOUSE; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT OUTCOME; TUMOR VOLUME; WEIGHT REDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG DELIVERY SYSTEMS; HYPERBARIC OXYGENATION; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED CBA; MICELLES; MICROSCOPY, ELECTRON, SCANNING; PERMEABILITY; REACTIVE OXYGEN SPECIES;

EID: 34547677807     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.1080/10611860701499839     Document Type: Article

References (35)

1. Chen, Q., Huang, Z., Chen, H., Shapiro, H., Beckers, J. and Hetzel, FW (2002) Improvement of tumor response by manipulation of tumor oxygenation during photodynamic therapy. Photochem Photobiol, 76, pp. 197-203.
2. Daruwalla, J. and Christophi, C. (2006) The effect of hyperbaric oxygen therapy on colorectal cancer liver metastases in a murine model. Eur J Cancer, 42, pp. 3304-3311.
3. Daruwalla, J. and Christophi, C. (2006) Hyperbaric oxygen therapy for malignancy: A review. World J Surg, 30, pp. 2112-2131.
4. Marco, A Di, Gaetani, M. and Scarpinato, B. (1969) Adriamycin (NSC-123,127): A new antibiotic with antitumor activity. Cancer Chemother Rep, 53, pp. 33-37.
5. Enomoto, K., Abe, O., Tominaga, T., Abe, R., Iino, Y., Koyama, H., Fujimoto, M. and Nomura, Y. (1990) Clinical study of pirarubicin for breast cancer in Japan. Clinical study group of THP for breast cancer in Japan. Am J Clin Oncol, 13, pp. S48-S53.
6. Feldmeier, J., Carl, U., Hartmann, K. and Sminia, P. (2003) Hyperbaric oxygen: Does it promote growth or recurrence of malignancy?. Undersea Hyperb Med, 30, pp. 1-18.
7. Gray, L., Conger, D. and Ebert, M. (1953) The concentration of oxygen dissolved in tissue at the time or irradiation as factor in radiotherapy. Br J Radiol, 26, pp. 638-648.
8. Greish, K., Fang, J., Inutsuka, T., Nagamitsu, A. and Maeda, H. (2003) Macromolecular therapeutics: Advantages and prospects with special emphasis on solid tumour targeting. Clin Pharmacokinet, 42, pp. 1089-1105.
9. Greish, K., Sawa, T., Fang, J., Akaike, T. and Maeda, H. (2004) SMA-doxorubicin, a new polymeric micellar drug for effective targeting to solid tumours. J Control Release, 97, pp. 219-230.
10. Greish, K., Nagamitsu, A., Fang, J. and Maeda, H. (2005) Copoly(styrene-maleic acid)-pirarubicin micelles: High tumor-targeting efficiency with little toxicity. Bioconjug Chem, 16, pp. 230-236.
11. Huang, Z., Chen, Q., Shakil, A., Chen, H., Beckers, J., Shapiro, H. and Hetzel, FW (2003) Hyperoxygenation enhances the tumor cell killing of photofrin-mediated photodynamic therapy. Photochem Photobiol, 78, pp. 496-502.
12. Hunt, TK (1988) The physiology of wound healing. Ann Emerg Med, 17, pp. 1265-1273.
13. Iwai, K., Maeda, H. and Konno, T. (1984) Use of oily contrast medium for selective drug targeting to tumor: Enhanced therapeutic effect and X-ray image. Cancer Res, 44, pp. 2115-2121.
14. Iyer, AK, Khaled, G., Fang, J. and Maeda, H. (2006) Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov Today, 11, pp. 812-818.
15. Kimura, K. (1986) A phase II study of (2″R)-4′-0-tetrahydropyranyladriamycin (THP) in patients with hematological malignancies. THP study group. Gan To Kagaku Ryoho, 13, pp. 368-375.
16. Koukourakis, MI, Giatromanolaki, A., Skarlatos, J., Corti, L., Blandamura, S., Piazza, M., Gatter, KC and Harris, AL (2001) Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy. Cancer Res, 61, pp. 1830-1832.
17. Kunimoto, S., Miura, K., Takahashi, Y., Takeuchi, T. and Umezawa, H. (1983) Rapid uptake by cultured tumor cells and intracellular behaviour of 4′-O-tetrahydro-pyranyladriamycin. J Antibiot, 36, pp. 312-317.
18. Kuruppu, D., Christophi, C., Bertram, JF and O'Brien, PE (1996) Characterization of an animal model of hepatic metastasis. J Gastroenterol Hepatol, 11, pp. 26-32.
19. Lian, QL, Hang, RC, Yan, HF, Chen, T., Ni, GT, Lu, HQ, Liu, YY and Liu, XQ (1995) Effects of hyperbaric oxygen on S-180 sarcoma in mice. Undersea Hyperb Med, 22, pp. 153-160.
20. Maeda, H. and Matsumura, Y. (1989) Tumoritropic and lymphotropic principles of macromolecular drugs. Crit Rev Ther Drug Carrier Syst, 6, pp. 193-210.
21. Marx, RE and Johnson, RP (1987) Studies in the radiobiology of osteoradionecrosis and their clinical significance. Oral Surg Oral Med Oral Pathol, 64, pp. 379-390.
22. Marx, RE, Ehler, WJ, Tayapongsak, P. and Pierce, LW (1990) Relationship of oxygen dose to angiogenesis induction in irradiated tissue. Am J Surg, 160, pp. 519-524.
23. Matsumura, Y. and Maeda, H. (1986) A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res, 46, pp. 6387-6392.
24. Mayer, R., Hamilton-Farrell, MR, van der Kleij, AJ, Schmutz, J., Granstrom, G., Sicko, Z., Melamed, Y., Carl, UM, Hartmann, KA, Jansen, EC, Ditri, L. and Sminia, P. (2005) Hyperbaric oxygen and radiotherapy. Strahlenther Onkol, 181, pp. 113-123.
25. McMillan, T., Calhoun, KH, Mader, JT, Stiernberg, CM and Rajaraman, S. (1989) The effect of hyperbaric oxygen therapy of oral mucosal carcinoma. Laryngoscope, 99, pp. 241-244.
26. Muller, I., Jenner, A., Bruchelt, G., Niethammer, D. and Halliwell, B. (1997) Effect of concentration on the cytotoxic mechanism of doxorubicin-apoptosis and oxidative DNA damage. Biochem Biophys Res Commun, 230, pp. 254-257.
27. Petre, PM, Baciewicz Jr., FA, Tigan, S. and Spears, JR (2003) Hyperbaric oxygen as a chemotherapy adjuvant in the treatment of metastatic lung tumors in a rat model. J Thorac Cardiovasc Surg, 125, pp. 85-95.
28. Phillips, SJ (2000) Physiology of wound healing and surgical wound care. ASAIO J, 46, pp. 52-55.
29. Shewell, J. and Thompson, SC (1980) The effect of hyperbaric oxygen treatment on pulmonary metastasis in the C3H mouse. Eur J Cancer, 16, pp. 253-259.
30. Sugiyama, T., Sadzuka, Y., Nagasawa, K., Noriaki, O. and Teruyoshi, YT (1999) Membrane transport and antitumor activity of pirarubicin, and comparison with those of doxorubicin. Jpn J Cancer Res, 90, pp. 775-780.
31. Teicher, BA, Lazo, JS and Sartorelli, AC (1981) Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells. Cancer Res, 41, pp. 73-81.
32. Thom, SR (1992) Hyperbaric oxygen therapy. A committee report, 20814, Undersea and Hyperbaric Medical Society, Bethseda
33. Tsuruo, T., Iida, H., Tsukagoshi, S. and Sakurai, Y. (1982) 4′-O-tetrahydropyranyladriamycin as a potential new antitumor agent. Cancer Res, 42, pp. 1462-1467.
34. Valaitis, J., Van Elk, J. and Staley, CJ (1968) Effect of hyperbaric oxygen and nitrogen mustard (NSC-762) on ehrlich ascites tumor. Cancer Chemother Rep, 52, pp. 405-412.
35. Yoon, S. and Tanabe, K. (1999) Surgical treatment and other regional treatments for colorectal cancer liver metastases. Oncologist, 4, pp. 197-208.